Charles J. Dimitroff
Professor, with Tenure, Department of Translational Medicine
Director, Translational Glycobiology Institute at Florida International University
Charles Dimitroff, PhD, is a global leader in the study of sugars, known as glycobiology, and is highly motivated to translate glycobiological findings to help cure diseases and improve the overall health of humans. His research focuses on understanding how sugars or ‘glycans’ regulate immune and cancer cell functions with the goal of developing new approaches to boost the immune system to fight diseases and to treat cancer progression. As a principal investigator for over 26 years, his efforts have helped identify the nature and impact of glycans on inflammation and cancer, while operating one of the most reputable translational glycobiology programs in the US.
Dr. Dimitroff’s administrative duties and laboratory is grounded within the Department of Translational Medicine in the Herbert Wertheim College of Medicine (HWCOM) at Florida International University (FIU). His laboratory is located in the Translational Glycobiology Institute at FIU (TGIF), in which he serves as its Founding Director. At the TGIF, he fosters collaborative glycoscience activities in medicine while training the next generation of basic and clinical research scientists in the glycosciences.